Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-18-001613
Filing Date
2018-02-13
Accepted
2018-02-13 20:08:34
Documents
1
Period of Report
2018-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_151857049936322.html 4  
1 FORM 4 wf-form4_151857049936322.xml 4 5687
  Complete submission text file 0001628280-18-001613.txt   7355
Mailing Address 17901 VON KARMAN AVENUE, SUITE 150 IRVINE CA 92614
Business Address 17901 VON KARMAN AVENUE, SUITE 150 IRVINE CA 92614 (949) 284-4555
Evolus, Inc. (Issuer) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 18191 VON KARMAN AVENUE SUITE 500 IRVINE CA 92612
Business Address 18191 VON KARMAN AVENUE SUITE 500 IRVINE CA 92612 949-284-4555
Alphaeon Corp (Reporting) CIK: 0001622667 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38381 | Film No.: 18606453
SIC: 5047 Wholesale-Medical, Dental & Hospital Equipment & Supplies